4-tert-ButylbenzhydroxaMic Acid
- $1175 - $3760
- Product name: 4-tert-ButylbenzhydroxaMic Acid
- CAS: 62034-73-5
- MF: C11H15NO2
- MW: 193.24
- EINECS:
- MDL Number:MFCD09938674
- Synonyms:4-tert-ButylbenzhydroxaMic Acid;Benzamide, 4-(1,1-dimethylethyl)-N-hydroxy-;4 (tert Butyl) benzhydroxamic Acid,4(tertButyl)benzhydroxamic Acid
3 prices
Selected condition:
Brand
- Matrix Scientific
- TRC
Package
- 500mg
- 5g
- 25g
- ManufacturerMatrix Scientific
- Product number145051
- Product description4-tert-Butyl-N-hydroxybenzamide 95%
- Packaging5g
- Price$1175
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number145051
- Product description4-tert-Butyl-N-hydroxybenzamide 95%
- Packaging25g
- Price$3760
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB691145
- Product description4-tert-ButylbenzhydroxamicAcid
- Packaging500mg
- Price$1260
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Matrix Scientific | 145051 | 4-tert-Butyl-N-hydroxybenzamide 95% | 5g | $1175 | 2021-12-16 | Buy |
Matrix Scientific | 145051 | 4-tert-Butyl-N-hydroxybenzamide 95% | 25g | $3760 | 2021-12-16 | Buy |
TRC | B691145 | 4-tert-ButylbenzhydroxamicAcid | 500mg | $1260 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|
Description
4-(tert-Butyl)benzhdroxamic Acid has shown signs of inhibition against histone deacetylases for application in the treatment of cancer. In addition this molecule displays antagonistic activity of PqsR (Pseudomonas aeruginose Transcriptional Regulator).Suppliers and manufacturers
TargetMol Chemicals Inc.
J & K SCIENTIFIC LTD.
Shanghai TaoSu Biochemical Technology Co., Ltd.
Henan Alfachem Co.,Ltd.
Shenzhen Polymeri Biochemical Technology Co., Ltd.
Fan De(Beijing) Biotechnology Co., Ltd.
Energy Chemical
Jinan Jiuli Biotechnology Co. , Ltd.
Changzhou Bojia Biomedical Technology Co., Ltd.
TargetMol Chemicals Inc.